Rebecca J. Gum
Neuroscience Research
Global Pharmaceutical Research and Development
Abbott Laboratories
R4DL, AP9A-3
USA
Name/email consistency: high
- P2X receptor antagonists for pain management: examination of binding and physicochemical properties. Gum, R.J., Wakefield, B., Jarvis, M.F. Purinergic Signal. (2012)
- Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Gum, R.J., Gaede, L.L., Koterski, S.L., Heindel, M., Clampit, J.E., Zinker, B.A., Trevillyan, J.M., Ulrich, R.G., Jirousek, M.R., Rondinone, C.M. Diabetes (2003)
- Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice. Gum, R.J., Gaede, L.L., Heindel, M.A., Waring, J.F., Trevillyan, J.M., Zinker, B.A., Stark, M.E., Wilcox, D., Jirousek, M.R., Rondinone, C.M., Ulrich, R.G. Mol. Endocrinol. (2003)
- Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1). Gum, R.J., Hickman, D., Fagerland, J.A., Heindel, M.A., Gagne, G.D., Schmidt, J.M., Michaelides, M.R., Davidsen, S.K., Ulrich, R.G. Biochem. Pharmacol. (2001)